Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 2.03, 9.01 · 8-K

MPT Operating Partnership, L.P.

Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Item 1.01. Entry into a Material Definitive Agreement. On August 10, 2026, MPT Operating Partnership, L.P. (the “Operating Partnership”), a Delaware limited partnership and the operating partnership of Medical Properties Trust, Inc., a Maryland corporation (the “Company” or “MPT”), and MPT Finance Corporation, a Delaware corporation and wholly owned subsidiary of the Operating Partnership (togethe…

Filed Aug 10, 2026Accepted Aug 10, 2026, 5:23 PM EDTCIK 1524607Accession 0001193125-26-342713
Share

Recent company filings

  1. 10-Q filingNov 6, 2026
  2. Results of Operations and Financial Condition · Regulation FD DisclosureAug 10, 2026
  3. 10-Q filingNov 10, 2025
  4. CORRESP filingOct 26, 2018
  5. 15-15D filingMay 9, 2013

Registered securities in this filing

MEDICAL PROPERTIES TRUST INC · 8-K · Filed 2026-08-10

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.

Symbol
MPT
Exchange
NYSE
Classification
COMMON
Filing context

Context: P08_10_2026To08_10_2026

Dimensions: Not supplied

Accession 000119312526342713 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 2.03, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive Agreement. On August 10, 2026, MPT Operating Partnership, L.P. (the “Operating Partnership”), a Delaware limited partnership and the operating partnership of Medical Properties Trust, Inc., a Maryland corporation (the “Company” or “MPT”), and MPT Finance Corporation, a Delaware corporation and wholly owned subsidiary of the Operating Partnership (together with the Operating Partnership, the “Issuers”) closed a series of previously announced transactions under an exchange and purchase agreement with certain institutional investors providing for a private placement for new money, together with a private exchange for outstanding senior notes, resulting in the issuance of $2.4 billion in aggregate principal amount of new 9.25% senior secured notes due 2032 (the “Notes”). The Issuers intend to use the net cash proceeds from the issuance to fund the redemption in full of the Issuers’ senior notes due 2026 and a partial redemption of the Issuers’ senior notes due 2027. In addition, the private exchange refinanced approximately $1.5 billion aggregate principal amount of 2027, 2028, 2029, 2030, and 2031 unsecured notes. The Notes were issued pursuant to an indenture, dated as of August 10, 2026 (the “Indenture”), by and among the Company, the Issuers, the subsidiary guarantors party thereto and Wilmington Trust, National Association, as trustee and collateral agent. Interest on the Notes is payable semi-annually in arrears on December 15 and June 15 of each year, commencing on December 15, 2026. The Notes mature on February 15, 2032. The Issuers may redeem some or all of the Notes at any time on or prior to August 10, 2028 at a “make-whole” redemption price. On or after August 10, 2028, the Issuers may redeem some or all of the Notes at a premium that will decrease over time. In addition, at any time and from time to time prior to August 10, 2028, the Issuers may redeem up to 40% of the Notes at a redemption price equal to 109.250% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon to, but excluding, the redemption date, using the proceeds from one or more equity offerings. The Notes are fully and unconditionally guaranteed, on a joint and several basis, by (i) the Company, (ii) its first-priority lien collateral-owning subsidiaries (the “First Lien Guarantors”), (iii) certain of the subsidiaries that guarantee the existing U.S. revolving credit and term loan facility (the “Credit Agreement”) and the 8.50% senior secured notes due 2032 and 7.00% senior secured notes due 2032 (together, the “Existing Secured Notes”) and (iv) certain additional subsidiaries that are direct or indirect parents of certain subsidiaries securing the British term loan facility (the “British Term Loan Facility”) or are owners of certain of the Company’s joint venture interests and equity investments. The Notes will be further guaranteed, subject to certain limitations set forth in the Indenture, by any restricted subsidiaries that in the future borrow under or guarantee borrowings under the Credit Agreement or Existing Secured Notes, or that guarantee certain capital markets indebtedness. The Notes and guarantees are secured, subject to certain permitted liens, by first-priority liens on the equity of each of the First Lien Guarantors and, subject to certain foreign collateral limitations, mortgages on the real properties owned by each of the First Lien Guarantors. The Notes will, upon the refinancing, replacement or termination of the Credit Agreement, become secured by second-priority liens on the collateral securing the Credit Agreement and Existing Secured Notes, subject to certain requirements and provisions for temporary alternative credit support set forth in the Indenture. In addition, at the Additional 1L Collateral Release Time (as defined in the Indenture), (i) the Notes will receive additional credit support from certain additional subsidiaries securing the British Term Loan Facility and (ii) the guarantees by, and first-priority liens in respect of, certain First Lien Guarantors will be released. Upon the occurrence of a Change of Control (as defined in the Indenture), each holder of the Notes may require the Issuers to repurchase some or all of its Notes at a repurchase price equal to 101% of the aggregate principal amount of such Notes, plus accrued and unpaid interest, if any, up to, but excluding, the date of purchase. The Indenture restricts the Issuers’ ability and the ability of their restricted subsidiaries to, among other things: (i) incur debt; (ii) pay dividends and make investments; (iii) create liens; (iv) enter into transactions with affiliates; and (v) merge, consolidate or transfer all or substantially all of their assets. The Indenture also requires the Issuers and their restricted subsidiaries to maintain total unencumbered assets of at least 150% of their collective unsecured debt. All of these covenants are subject to a number of important limitations and exceptions under the Indenture. The Indenture also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Notes, as applicable, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, the failure of the liens created by the security documents to constitute valid and perfected liens on any material portion of the collateral securing the Notes for a specified period of time after notice and certain events of insolvency. If an Event of Default (as defined in the Indenture) occurs and is continuing, the Trustee or the holders of at least 25% in aggregate principal amount of the outstanding Notes may declare the Notes immediately due and payable, except that an Event of Default resulting from certain events of insolvency with respect to an Issuer will automatically cause the Notes to become immediately due and payable without any declaration or other act on the part of the Trustee or any holders of Notes.
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. The disclosure set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. No Offer or Sale MPT is offering and selling the Notes and related guarantees only by, and pursuant to, the terms of an exchange and purchase agreement with certain institutional investors. The Notes have not been registered under the Securities Act of 1933 (the “Securities Act”), or any other securities laws, and the Notes cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
Filed exhibits (1)
EX-4.1 (by filename) d135389dex41.htm

EX-4.1 2 d135389dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 Execution Version INDENTURE Dated as of August 10, 2026 Among MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as the Issuers, and MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor, and SUBSIDIARIES PARTY HERETO, as Subsidiary Guarantors, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee, Paying Agent, Registrar, Transfer Agent and Notes Collateral Agent, $2,400,000,000 9.250% SENIOR SECURED NOTES DUE 2032 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 45 Section 1.03. Rules of Construction 46 Section 1.04. Acts of Holders 47 Section 1.05. …

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.